In the present study, we demonstrated that serum concentrations of bone sialoprotein (BSP) are elevated in a cohort of 132 patients who underwent radical tumor resection for pancreatic cancer and that high pre-operative BSP levels represent a significant marker for an unfavourable patients ́ prognosis. The gene discussed is IBSP; the disease is pancreatic neoplasm.